Skip to main content
Chentian Shen on Muck Rack

Chentian Shen

As seen in: Frontiers, Cell Reports Medicine
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Chentian

Contact Chentian, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Proteogenomic characterization delineates clinically relevant subtypes of advanced differentiated thyroid cancer

|
By Tingting Zhang, Haitao Tang, Cenkai Shen, Yan Zhang, Yaoting Sun, Yan Zhou, Chentian Shen, Huajun Xu, Chenyi Wang, Wenyang Ding, Tiansheng Xu, Yuxin Du, Zhiyan Liu, Yulong Wang, Dongmei Ji, Xing Sun, Qinghai Ji, Wenjun Wei, Yu Wang, Xiao Shi, Wangpeng Cui, Fuxing Zheng, Chuqiao Liu, Naisi Huang, Xiaoqi Mao
| Cell Reports Medicine Verified
ArticleOnline now102661Open access Affiliations & Notes 1Department of Head and Neck Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China 2Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China 3Department of Pathology, Shanghai Medical College, Fudan University, Shanghai 200032, China 4Westlake Center for Intelligent Proteomics, School of Life Sciences, Westlake University, Hangzhou 310024, China 5Department of Nuclear Medicine,...
Open in Who Shared Issue with article?

A preliminary study to evaluate efficacy and safety of Lugol’s solution following radioiodine for remnant ablation in differentiated thyroid cancer

|
By Jiangfeng Wang, Yunyun Zhu, Quanyong Luo, Chentian Shen
| Frontiers
Abstract Purpose: This randomized controlled trial aimed to determine if Lugol’s solution following radioactive iodine (RAI) therapy enhances the efficacy of ablation and mitigates radiation-induced toxicity in patients with differentiated thyroid cancer. Methods: In this prospective study, 97 patients were enrolled and randomized to control group (RAI) and test group (RAI + Lugol’s solution). The primary endpoint was the rate of successful ablation.
Open in Who Shared Issue with article?
|
By Wojciech Lesniak, Srikanth Boinapally, Sangeeta Ray Banerjee, Babak Azad, Ala Lisok, Bryan Wharram, Martin G. Pomper, Catherine A. Foss, Chentian Shen, Sridhar Nimmagadda
| American Chemical Society
Open in Who Shared Issue with article?
See all 3 articles